Medical Care
Tuberculosis Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 551714
- Pages: 110
- Figures: 181
- Views: 1
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The global market for Tuberculosis Diagnostic was estimated to be worth US$ 2630 million in 2023 and is forecast to a readjusted size of US$ 3373.5 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Diagnostic, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Tuberculosis Diagnostic by region & country, by Type, and by Application.
The Tuberculosis Diagnostic market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Diagnostic.
Market Segmentation
By Company
Thermo Fisher Scientific
Hologic Corporation
Abbott
Becton Dickinson
Roche
bioMerieux
Sanofi
Cepheid
Hain Lifescience
QIAGEN
Segment by Type:
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Segment by Application
Infants
Adults
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Tuberculosis Diagnostic manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Tuberculosis Diagnostic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Tuberculosis Diagnostic in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Tuberculosis Diagnostic was estimated to be worth US$ 2630 million in 2023 and is forecast to a readjusted size of US$ 3373.5 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Diagnostic, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Tuberculosis Diagnostic by region & country, by Type, and by Application.
The Tuberculosis Diagnostic market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Diagnostic.
Market Segmentation
By Company
Thermo Fisher Scientific
Hologic Corporation
Abbott
Becton Dickinson
Roche
bioMerieux
Sanofi
Cepheid
Hain Lifescience
QIAGEN
Segment by Type:
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Segment by Application
Infants
Adults
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Tuberculosis Diagnostic manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Tuberculosis Diagnostic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Tuberculosis Diagnostic in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Tuberculosis Diagnostic Product Introduction
1.2 Global Tuberculosis Diagnostic Market Size Forecast
1.3 Tuberculosis Diagnostic Market Trends & Drivers
1.3.1 Tuberculosis Diagnostic Industry Trends
1.3.2 Tuberculosis Diagnostic Market Drivers & Opportunity
1.3.3 Tuberculosis Diagnostic Market Challenges
1.3.4 Tuberculosis Diagnostic Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Tuberculosis Diagnostic Players Revenue Ranking (2023)
2.2 Global Tuberculosis Diagnostic Revenue by Company (2019-2024)
2.3 Key Companies Tuberculosis Diagnostic Manufacturing Base Distribution and Headquarters
2.4 Key Companies Tuberculosis Diagnostic Product Offered
2.5 Key Companies Time to Begin Mass Production of Tuberculosis Diagnostic
2.6 Tuberculosis Diagnostic Market Competitive Analysis
2.6.1 Tuberculosis Diagnostic Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Tuberculosis Diagnostic Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Radiographic Method
3.1.2 Diagnostic Laboratory Methods
3.1.3 Nucleic Acid Testing
3.1.4 Phage Assay
3.1.5 Detection of Latent Infection
3.1.6 Cytokine Detection Assay
3.1.7 Detection of Drug Resistance
3.2 Global Tuberculosis Diagnostic Sales Value by Type
3.2.1 Global Tuberculosis Diagnostic Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Tuberculosis Diagnostic Sales Value, by Type (2019-2030)
3.2.3 Global Tuberculosis Diagnostic Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Infants
4.1.2 Adults
4.2 Global Tuberculosis Diagnostic Sales Value by Application
4.2.1 Global Tuberculosis Diagnostic Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Tuberculosis Diagnostic Sales Value, by Application (2019-2030)
4.2.3 Global Tuberculosis Diagnostic Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Tuberculosis Diagnostic Sales Value by Region
5.1.1 Global Tuberculosis Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Tuberculosis Diagnostic Sales Value by Region (2019-2024)
5.1.3 Global Tuberculosis Diagnostic Sales Value by Region (2025-2030)
5.1.4 Global Tuberculosis Diagnostic Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Tuberculosis Diagnostic Sales Value, 2019-2030
5.2.2 North America Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Tuberculosis Diagnostic Sales Value, 2019-2030
5.3.2 Europe Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Tuberculosis Diagnostic Sales Value, 2019-2030
5.4.2 Asia Pacific Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Tuberculosis Diagnostic Sales Value, 2019-2030
5.5.2 South America Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Tuberculosis Diagnostic Sales Value, 2019-2030
5.6.2 Middle East & Africa Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Tuberculosis Diagnostic Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Tuberculosis Diagnostic Sales Value
6.3 United States
6.3.1 United States Tuberculosis Diagnostic Sales Value, 2019-2030
6.3.2 United States Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Tuberculosis Diagnostic Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Tuberculosis Diagnostic Sales Value, 2019-2030
6.4.2 Europe Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Tuberculosis Diagnostic Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Tuberculosis Diagnostic Sales Value, 2019-2030
6.5.2 China Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
6.5.3 China Tuberculosis Diagnostic Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Tuberculosis Diagnostic Sales Value, 2019-2030
6.6.2 Japan Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Tuberculosis Diagnostic Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Tuberculosis Diagnostic Sales Value, 2019-2030
6.7.2 South Korea Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Tuberculosis Diagnostic Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Tuberculosis Diagnostic Sales Value, 2019-2030
6.8.2 Southeast Asia Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Tuberculosis Diagnostic Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Tuberculosis Diagnostic Sales Value, 2019-2030
6.9.2 India Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
6.9.3 India Tuberculosis Diagnostic Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Hologic Corporation
7.2.1 Hologic Corporation Profile
7.2.2 Hologic Corporation Main Business
7.2.3 Hologic Corporation Tuberculosis Diagnostic Products, Services and Solutions
7.2.4 Hologic Corporation Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.2.5 Hologic Corporation Recent Developments
7.3 Abbott
7.3.1 Abbott Profile
7.3.2 Abbott Main Business
7.3.3 Abbott Tuberculosis Diagnostic Products, Services and Solutions
7.3.4 Abbott Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.3.5 Becton Dickinson Recent Developments
7.4 Becton Dickinson
7.4.1 Becton Dickinson Profile
7.4.2 Becton Dickinson Main Business
7.4.3 Becton Dickinson Tuberculosis Diagnostic Products, Services and Solutions
7.4.4 Becton Dickinson Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.4.5 Becton Dickinson Recent Developments
7.5 Roche
7.5.1 Roche Profile
7.5.2 Roche Main Business
7.5.3 Roche Tuberculosis Diagnostic Products, Services and Solutions
7.5.4 Roche Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.5.5 Roche Recent Developments
7.6 bioMerieux
7.6.1 bioMerieux Profile
7.6.2 bioMerieux Main Business
7.6.3 bioMerieux Tuberculosis Diagnostic Products, Services and Solutions
7.6.4 bioMerieux Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.6.5 bioMerieux Recent Developments
7.7 Sanofi
7.7.1 Sanofi Profile
7.7.2 Sanofi Main Business
7.7.3 Sanofi Tuberculosis Diagnostic Products, Services and Solutions
7.7.4 Sanofi Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.7.5 Sanofi Recent Developments
7.8 Cepheid
7.8.1 Cepheid Profile
7.8.2 Cepheid Main Business
7.8.3 Cepheid Tuberculosis Diagnostic Products, Services and Solutions
7.8.4 Cepheid Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.8.5 Cepheid Recent Developments
7.9 Hain Lifescience
7.9.1 Hain Lifescience Profile
7.9.2 Hain Lifescience Main Business
7.9.3 Hain Lifescience Tuberculosis Diagnostic Products, Services and Solutions
7.9.4 Hain Lifescience Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.9.5 Hain Lifescience Recent Developments
7.10 QIAGEN
7.10.1 QIAGEN Profile
7.10.2 QIAGEN Main Business
7.10.3 QIAGEN Tuberculosis Diagnostic Products, Services and Solutions
7.10.4 QIAGEN Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.10.5 QIAGEN Recent Developments
8 Industry Chain Analysis
8.1 Tuberculosis Diagnostic Industrial Chain
8.2 Tuberculosis Diagnostic Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Tuberculosis Diagnostic Sales Model
8.5.2 Sales Channel
8.5.3 Tuberculosis Diagnostic Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Tuberculosis Diagnostic Product Introduction
1.2 Global Tuberculosis Diagnostic Market Size Forecast
1.3 Tuberculosis Diagnostic Market Trends & Drivers
1.3.1 Tuberculosis Diagnostic Industry Trends
1.3.2 Tuberculosis Diagnostic Market Drivers & Opportunity
1.3.3 Tuberculosis Diagnostic Market Challenges
1.3.4 Tuberculosis Diagnostic Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Tuberculosis Diagnostic Players Revenue Ranking (2023)
2.2 Global Tuberculosis Diagnostic Revenue by Company (2019-2024)
2.3 Key Companies Tuberculosis Diagnostic Manufacturing Base Distribution and Headquarters
2.4 Key Companies Tuberculosis Diagnostic Product Offered
2.5 Key Companies Time to Begin Mass Production of Tuberculosis Diagnostic
2.6 Tuberculosis Diagnostic Market Competitive Analysis
2.6.1 Tuberculosis Diagnostic Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Tuberculosis Diagnostic Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Radiographic Method
3.1.2 Diagnostic Laboratory Methods
3.1.3 Nucleic Acid Testing
3.1.4 Phage Assay
3.1.5 Detection of Latent Infection
3.1.6 Cytokine Detection Assay
3.1.7 Detection of Drug Resistance
3.2 Global Tuberculosis Diagnostic Sales Value by Type
3.2.1 Global Tuberculosis Diagnostic Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Tuberculosis Diagnostic Sales Value, by Type (2019-2030)
3.2.3 Global Tuberculosis Diagnostic Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Infants
4.1.2 Adults
4.2 Global Tuberculosis Diagnostic Sales Value by Application
4.2.1 Global Tuberculosis Diagnostic Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Tuberculosis Diagnostic Sales Value, by Application (2019-2030)
4.2.3 Global Tuberculosis Diagnostic Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Tuberculosis Diagnostic Sales Value by Region
5.1.1 Global Tuberculosis Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Tuberculosis Diagnostic Sales Value by Region (2019-2024)
5.1.3 Global Tuberculosis Diagnostic Sales Value by Region (2025-2030)
5.1.4 Global Tuberculosis Diagnostic Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Tuberculosis Diagnostic Sales Value, 2019-2030
5.2.2 North America Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Tuberculosis Diagnostic Sales Value, 2019-2030
5.3.2 Europe Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Tuberculosis Diagnostic Sales Value, 2019-2030
5.4.2 Asia Pacific Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Tuberculosis Diagnostic Sales Value, 2019-2030
5.5.2 South America Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Tuberculosis Diagnostic Sales Value, 2019-2030
5.6.2 Middle East & Africa Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Tuberculosis Diagnostic Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Tuberculosis Diagnostic Sales Value
6.3 United States
6.3.1 United States Tuberculosis Diagnostic Sales Value, 2019-2030
6.3.2 United States Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Tuberculosis Diagnostic Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Tuberculosis Diagnostic Sales Value, 2019-2030
6.4.2 Europe Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Tuberculosis Diagnostic Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Tuberculosis Diagnostic Sales Value, 2019-2030
6.5.2 China Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
6.5.3 China Tuberculosis Diagnostic Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Tuberculosis Diagnostic Sales Value, 2019-2030
6.6.2 Japan Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Tuberculosis Diagnostic Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Tuberculosis Diagnostic Sales Value, 2019-2030
6.7.2 South Korea Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Tuberculosis Diagnostic Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Tuberculosis Diagnostic Sales Value, 2019-2030
6.8.2 Southeast Asia Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Tuberculosis Diagnostic Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Tuberculosis Diagnostic Sales Value, 2019-2030
6.9.2 India Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
6.9.3 India Tuberculosis Diagnostic Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Hologic Corporation
7.2.1 Hologic Corporation Profile
7.2.2 Hologic Corporation Main Business
7.2.3 Hologic Corporation Tuberculosis Diagnostic Products, Services and Solutions
7.2.4 Hologic Corporation Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.2.5 Hologic Corporation Recent Developments
7.3 Abbott
7.3.1 Abbott Profile
7.3.2 Abbott Main Business
7.3.3 Abbott Tuberculosis Diagnostic Products, Services and Solutions
7.3.4 Abbott Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.3.5 Becton Dickinson Recent Developments
7.4 Becton Dickinson
7.4.1 Becton Dickinson Profile
7.4.2 Becton Dickinson Main Business
7.4.3 Becton Dickinson Tuberculosis Diagnostic Products, Services and Solutions
7.4.4 Becton Dickinson Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.4.5 Becton Dickinson Recent Developments
7.5 Roche
7.5.1 Roche Profile
7.5.2 Roche Main Business
7.5.3 Roche Tuberculosis Diagnostic Products, Services and Solutions
7.5.4 Roche Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.5.5 Roche Recent Developments
7.6 bioMerieux
7.6.1 bioMerieux Profile
7.6.2 bioMerieux Main Business
7.6.3 bioMerieux Tuberculosis Diagnostic Products, Services and Solutions
7.6.4 bioMerieux Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.6.5 bioMerieux Recent Developments
7.7 Sanofi
7.7.1 Sanofi Profile
7.7.2 Sanofi Main Business
7.7.3 Sanofi Tuberculosis Diagnostic Products, Services and Solutions
7.7.4 Sanofi Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.7.5 Sanofi Recent Developments
7.8 Cepheid
7.8.1 Cepheid Profile
7.8.2 Cepheid Main Business
7.8.3 Cepheid Tuberculosis Diagnostic Products, Services and Solutions
7.8.4 Cepheid Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.8.5 Cepheid Recent Developments
7.9 Hain Lifescience
7.9.1 Hain Lifescience Profile
7.9.2 Hain Lifescience Main Business
7.9.3 Hain Lifescience Tuberculosis Diagnostic Products, Services and Solutions
7.9.4 Hain Lifescience Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.9.5 Hain Lifescience Recent Developments
7.10 QIAGEN
7.10.1 QIAGEN Profile
7.10.2 QIAGEN Main Business
7.10.3 QIAGEN Tuberculosis Diagnostic Products, Services and Solutions
7.10.4 QIAGEN Tuberculosis Diagnostic Revenue (US$ Million) & (2019-2024)
7.10.5 QIAGEN Recent Developments
8 Industry Chain Analysis
8.1 Tuberculosis Diagnostic Industrial Chain
8.2 Tuberculosis Diagnostic Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Tuberculosis Diagnostic Sales Model
8.5.2 Sales Channel
8.5.3 Tuberculosis Diagnostic Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Tuberculosis Diagnostic Market Trends
Table 2. Tuberculosis Diagnostic Market Drivers & Opportunity
Table 3. Tuberculosis Diagnostic Market Challenges
Table 4. Tuberculosis Diagnostic Market Restraints
Table 5. Global Tuberculosis Diagnostic Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Tuberculosis Diagnostic Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Tuberculosis Diagnostic Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Tuberculosis Diagnostic Product Type
Table 9. Key Companies Time to Begin Mass Production of Tuberculosis Diagnostic
Table 10. Global Tuberculosis Diagnostic Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Tuberculosis Diagnostic Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Tuberculosis Diagnostic Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Tuberculosis Diagnostic Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Tuberculosis Diagnostic Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Tuberculosis Diagnostic Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Tuberculosis Diagnostic Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Tuberculosis Diagnostic Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Tuberculosis Diagnostic Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Tuberculosis Diagnostic Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Tuberculosis Diagnostic Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Tuberculosis Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Tuberculosis Diagnostic Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Tuberculosis Diagnostic Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Tuberculosis Diagnostic Sales Value by Region (2019-2024) & (%)
Table 27. Global Tuberculosis Diagnostic Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Tuberculosis Diagnostic Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Tuberculosis Diagnostic Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Tuberculosis Diagnostic Sales Value, (2025-2030) & (US$ Million)
Table 31. Thermo Fisher Scientific Basic Information List
Table 32. Thermo Fisher Scientific Description and Business Overview
Table 33. Thermo Fisher Scientific Tuberculosis Diagnostic Products, Services and Solutions
Table 34. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Thermo Fisher Scientific (2019-2024)
Table 35. Thermo Fisher Scientific Recent Developments
Table 36. Hologic Corporation Basic Information List
Table 37. Hologic Corporation Description and Business Overview
Table 38. Hologic Corporation Tuberculosis Diagnostic Products, Services and Solutions
Table 39. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Hologic Corporation (2019-2024)
Table 40. Hologic Corporation Recent Developments
Table 41. Abbott Basic Information List
Table 42. Abbott Description and Business Overview
Table 43. Abbott Tuberculosis Diagnostic Products, Services and Solutions
Table 44. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Abbott (2019-2024)
Table 45. Abbott Recent Developments
Table 46. Becton Dickinson Basic Information List
Table 47. Becton Dickinson Description and Business Overview
Table 48. Becton Dickinson Tuberculosis Diagnostic Products, Services and Solutions
Table 49. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Becton Dickinson (2019-2024)
Table 50. Becton Dickinson Recent Developments
Table 51. Roche Basic Information List
Table 52. Roche Description and Business Overview
Table 53. Roche Tuberculosis Diagnostic Products, Services and Solutions
Table 54. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Roche (2019-2024)
Table 55. Roche Recent Developments
Table 56. bioMerieux Basic Information List
Table 57. bioMerieux Description and Business Overview
Table 58. bioMerieux Tuberculosis Diagnostic Products, Services and Solutions
Table 59. Revenue (US$ Million) in Tuberculosis Diagnostic Business of bioMerieux (2019-2024)
Table 60. bioMerieux Recent Developments
Table 61. Sanofi Basic Information List
Table 62. Sanofi Description and Business Overview
Table 63. Sanofi Tuberculosis Diagnostic Products, Services and Solutions
Table 64. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Sanofi (2019-2024)
Table 65. Sanofi Recent Developments
Table 66. Cepheid Basic Information List
Table 67. Cepheid Description and Business Overview
Table 68. Cepheid Tuberculosis Diagnostic Products, Services and Solutions
Table 69. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Cepheid (2019-2024)
Table 70. Cepheid Recent Developments
Table 71. Hain Lifescience Basic Information List
Table 72. Hain Lifescience Description and Business Overview
Table 73. Hain Lifescience Tuberculosis Diagnostic Products, Services and Solutions
Table 74. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Hain Lifescience (2019-2024)
Table 75. Hain Lifescience Recent Developments
Table 76. QIAGEN Basic Information List
Table 77. QIAGEN Description and Business Overview
Table 78. QIAGEN Tuberculosis Diagnostic Products, Services and Solutions
Table 79. Revenue (US$ Million) in Tuberculosis Diagnostic Business of QIAGEN (2019-2024)
Table 80. QIAGEN Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Tuberculosis Diagnostic Downstream Customers
Table 84. Tuberculosis Diagnostic Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Tuberculosis Diagnostic Product Picture
Figure 2. Global Tuberculosis Diagnostic Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Tuberculosis Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 4. Tuberculosis Diagnostic Report Years Considered
Figure 5. Global Tuberculosis Diagnostic Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Tuberculosis Diagnostic Revenue in 2023
Figure 7. Tuberculosis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Radiographic Method Picture
Figure 9. Diagnostic Laboratory Methods Picture
Figure 10. Nucleic Acid Testing Picture
Figure 11. Phage Assay Picture
Figure 12. Detection of Latent Infection Picture
Figure 13. Cytokine Detection Assay Picture
Figure 14. Detection of Drug Resistance Picture
Figure 15. Global Tuberculosis Diagnostic Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Tuberculosis Diagnostic Sales Value Market Share by Type, 2023 & 2030
Figure 17. Product Picture of Infants
Figure 18. Product Picture of Adults
Figure 19. Global Tuberculosis Diagnostic Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Tuberculosis Diagnostic Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Tuberculosis Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Tuberculosis Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Tuberculosis Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Tuberculosis Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Tuberculosis Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Tuberculosis Diagnostic Sales Value (%), (2019-2030)
Figure 32. United States Tuberculosis Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Tuberculosis Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Tuberculosis Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Tuberculosis Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 38. China Tuberculosis Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 40. China Tuberculosis Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Tuberculosis Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Tuberculosis Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Tuberculosis Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Tuberculosis Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Tuberculosis Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Tuberculosis Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 50. India Tuberculosis Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 52. India Tuberculosis Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 53. Tuberculosis Diagnostic Industrial Chain
Figure 54. Tuberculosis Diagnostic Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Table 1. Tuberculosis Diagnostic Market Trends
Table 2. Tuberculosis Diagnostic Market Drivers & Opportunity
Table 3. Tuberculosis Diagnostic Market Challenges
Table 4. Tuberculosis Diagnostic Market Restraints
Table 5. Global Tuberculosis Diagnostic Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Tuberculosis Diagnostic Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Tuberculosis Diagnostic Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Tuberculosis Diagnostic Product Type
Table 9. Key Companies Time to Begin Mass Production of Tuberculosis Diagnostic
Table 10. Global Tuberculosis Diagnostic Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Tuberculosis Diagnostic Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Tuberculosis Diagnostic Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Tuberculosis Diagnostic Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Tuberculosis Diagnostic Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Tuberculosis Diagnostic Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Tuberculosis Diagnostic Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Tuberculosis Diagnostic Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Tuberculosis Diagnostic Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Tuberculosis Diagnostic Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Tuberculosis Diagnostic Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Tuberculosis Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Tuberculosis Diagnostic Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Tuberculosis Diagnostic Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Tuberculosis Diagnostic Sales Value by Region (2019-2024) & (%)
Table 27. Global Tuberculosis Diagnostic Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Tuberculosis Diagnostic Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Tuberculosis Diagnostic Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Tuberculosis Diagnostic Sales Value, (2025-2030) & (US$ Million)
Table 31. Thermo Fisher Scientific Basic Information List
Table 32. Thermo Fisher Scientific Description and Business Overview
Table 33. Thermo Fisher Scientific Tuberculosis Diagnostic Products, Services and Solutions
Table 34. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Thermo Fisher Scientific (2019-2024)
Table 35. Thermo Fisher Scientific Recent Developments
Table 36. Hologic Corporation Basic Information List
Table 37. Hologic Corporation Description and Business Overview
Table 38. Hologic Corporation Tuberculosis Diagnostic Products, Services and Solutions
Table 39. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Hologic Corporation (2019-2024)
Table 40. Hologic Corporation Recent Developments
Table 41. Abbott Basic Information List
Table 42. Abbott Description and Business Overview
Table 43. Abbott Tuberculosis Diagnostic Products, Services and Solutions
Table 44. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Abbott (2019-2024)
Table 45. Abbott Recent Developments
Table 46. Becton Dickinson Basic Information List
Table 47. Becton Dickinson Description and Business Overview
Table 48. Becton Dickinson Tuberculosis Diagnostic Products, Services and Solutions
Table 49. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Becton Dickinson (2019-2024)
Table 50. Becton Dickinson Recent Developments
Table 51. Roche Basic Information List
Table 52. Roche Description and Business Overview
Table 53. Roche Tuberculosis Diagnostic Products, Services and Solutions
Table 54. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Roche (2019-2024)
Table 55. Roche Recent Developments
Table 56. bioMerieux Basic Information List
Table 57. bioMerieux Description and Business Overview
Table 58. bioMerieux Tuberculosis Diagnostic Products, Services and Solutions
Table 59. Revenue (US$ Million) in Tuberculosis Diagnostic Business of bioMerieux (2019-2024)
Table 60. bioMerieux Recent Developments
Table 61. Sanofi Basic Information List
Table 62. Sanofi Description and Business Overview
Table 63. Sanofi Tuberculosis Diagnostic Products, Services and Solutions
Table 64. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Sanofi (2019-2024)
Table 65. Sanofi Recent Developments
Table 66. Cepheid Basic Information List
Table 67. Cepheid Description and Business Overview
Table 68. Cepheid Tuberculosis Diagnostic Products, Services and Solutions
Table 69. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Cepheid (2019-2024)
Table 70. Cepheid Recent Developments
Table 71. Hain Lifescience Basic Information List
Table 72. Hain Lifescience Description and Business Overview
Table 73. Hain Lifescience Tuberculosis Diagnostic Products, Services and Solutions
Table 74. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Hain Lifescience (2019-2024)
Table 75. Hain Lifescience Recent Developments
Table 76. QIAGEN Basic Information List
Table 77. QIAGEN Description and Business Overview
Table 78. QIAGEN Tuberculosis Diagnostic Products, Services and Solutions
Table 79. Revenue (US$ Million) in Tuberculosis Diagnostic Business of QIAGEN (2019-2024)
Table 80. QIAGEN Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Tuberculosis Diagnostic Downstream Customers
Table 84. Tuberculosis Diagnostic Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Tuberculosis Diagnostic Product Picture
Figure 2. Global Tuberculosis Diagnostic Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Tuberculosis Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 4. Tuberculosis Diagnostic Report Years Considered
Figure 5. Global Tuberculosis Diagnostic Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Tuberculosis Diagnostic Revenue in 2023
Figure 7. Tuberculosis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Radiographic Method Picture
Figure 9. Diagnostic Laboratory Methods Picture
Figure 10. Nucleic Acid Testing Picture
Figure 11. Phage Assay Picture
Figure 12. Detection of Latent Infection Picture
Figure 13. Cytokine Detection Assay Picture
Figure 14. Detection of Drug Resistance Picture
Figure 15. Global Tuberculosis Diagnostic Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Tuberculosis Diagnostic Sales Value Market Share by Type, 2023 & 2030
Figure 17. Product Picture of Infants
Figure 18. Product Picture of Adults
Figure 19. Global Tuberculosis Diagnostic Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Tuberculosis Diagnostic Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Tuberculosis Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Tuberculosis Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Tuberculosis Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Tuberculosis Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Tuberculosis Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Tuberculosis Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Tuberculosis Diagnostic Sales Value (%), (2019-2030)
Figure 32. United States Tuberculosis Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Tuberculosis Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Tuberculosis Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Tuberculosis Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 38. China Tuberculosis Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 40. China Tuberculosis Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Tuberculosis Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Tuberculosis Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Tuberculosis Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Tuberculosis Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Tuberculosis Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Tuberculosis Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 50. India Tuberculosis Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Tuberculosis Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 52. India Tuberculosis Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 53. Tuberculosis Diagnostic Industrial Chain
Figure 54. Tuberculosis Diagnostic Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232